Scholar4AI Updated 2026-10-30 12:46 UTC+09:00

PharmacoEconomics - Open

Share: X LinkedIn Bluesky Threads Facebook Reddit Hacker News Hatena LINE Email
Copy:

4 papers in the last 7 days · category: Health Economics and Policy · publisher: Adis, Springer Healthcare · ISSN 2509-4254

← Papers per journal

Key findings#

  • PharmacoEconomics - Open published 12 papers in the last 30 days (2026-10-01 to 2026-10-30), ranking #82 of 392 journals.
  • Leading institutions: The University of Queensland (2), Imperial College London (2) and Bocconi University (2).
  • Countries: United States (5), United Kingdom (4) and Australia (2).
  • From Oct 2023 to Sep 2026, PharmacoEconomics - Open published 237 papers (7 a month on average, by publication date in OpenAlex).
  • Its most frequent keywords over that period were “cost-effectiveness” (89), “quality-adjusted life years” (74) and “health care costs” (41).
  • Its most-cited paper of the period is “Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models” (2024-02-10), with 71 citations.
  • Since October 2016, its most-cited paper is “National Healthcare Economic Evaluation Guidelines: A Cross-Country Comparison” (2021-01-10), with 114 citations.

The last 36 months#

Oct 23: 2 papersNov 23: 10 papersDec 23: 7 papersJan 24: 12 papersFeb 24: 4 papersMar 24: 6 papersApr 24: 7 papersMay 24: 5 papersJun 24: 4 papersJul 24: 13 papersAug 24: 10 papersSep 24: 5 papersOct 24: 7 papersNov 24: 9 papersDec 24: 6 papersJan 25: 9 papersFeb 25: 6 papersMar 25: 5 papersApr 25: 11 papersMay 25: 4 papersJun 25: 6 papersJul 25: 3 papersAug 25: 6 papersSep 25: 5 papersOct 25: 5 papersNov 25: 7 papersDec 25: 10 papersJan 26: 10 papersFeb 26: 3 papersMar 26: 6 papersApr 26: 6 papersMay 26: 7 papersJun 26: 6 papersJul 26: 5 papersAug 26: 5 papersSep 26: 5 papers
Oct 23Sep 26
Papers by publication date, Oct 2023 to Sep 2026
Oct 23–Sep 24Oct 24–Sep 25Oct 25–Sep 2636 months
857775237
Most frequent keywords, Oct 2023 to Sep 2026
#KeywordPapers
1cost-effectiveness89
2quality-adjusted life years74
3health care costs41
4health technology assessment25
5Markov model24
6economic burden22
7health-related quality of life19
8cost-utility analysis16
9health utility16
10healthcare resource utilization15

Most-cited since October 2016# All journals →

The journal's most-cited papers published since October 2016
#CitationsPer monthTitleJournalPublishedAuthors
11141.6National Healthcare Economic Evaluation Guidelines: A Cross-Country ComparisonPharmacoEconomics - Open2021-01-10Deepshikha Sharma, Arun Kumar Aggarwal, Laura Emily Downey et al.
2931.6Similarities and Differences in Health Technology Assessment Systems and Implications for Coverage Decisions: Evidence from 32 CountriesPharmacoEconomics - Open2021-11-29Anna-Maria Fontrier, Erica Visintin, Panos G. Kanavos
3901.4Hospital Costs of Extracorporeal Membrane Oxygenation in Adults: A Systematic ReviewPharmacoEconomics - Open2021-05-31Annemieke Oude Lansink‐Hartgring, Olivier van Minnen, Karin Marianne Vermeulen et al.
4871.0A Nationwide Study of Prevalence Rates and Characteristics of 199 Chronic Conditions in DenmarkPharmacoEconomics - Open2019-07-24Michael Falk Hvidberg, Søren Paaske Johnsen, Michael Davidsen et al.
5791.2Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?PharmacoEconomics - Open2021-03-04Giancarlo Pruneri, Filippo de Braud, Anna Sapino et al.
6750.7Health Technology Assessment for Policy Making in India: Current Scenario and Way ForwardPharmacoEconomics - Open2017-06-13Shankar Prinja, Laura Emily Downey, Vijay Kumar Gauba et al.
7712.2Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language ModelsPharmacoEconomics - Open2024-02-10Tim Reason, Emma Benbow, Julia Langham et al.
8660.6Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy ControlsPharmacoEconomics - Open2018-03-13Caroline C. Kingdon, Erinna W. Bowman, Hayley Curran et al.
9661.3A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital SettingPharmacoEconomics - Open2022-08-23Conor McCloskey, María Toboso Ortega, Sunita Nair et al.
10630.6Application of Discrete-Choice Experiment Methods in Tobacco Control: A Systematic ReviewPharmacoEconomics - Open2017-04-25Kabindra Regmi, Dinesh Kaphle, Sabina Timilsina et al.
Papers, newest first.
DateTitleJournalAuthorsAffiliations
2026-10-27Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of UncertaintyPharmacoEconomics - OpenNai-Chia Chen, Ash Bullement, Antal Tamás Zemplenyi et al.University of Colorado Anschutz; University of York; Brigham and Women's Hospital; …
2026-10-27Initiating Patients on Peritoneal Dialysis Compared with In-Centre Haemodialysis in the United Kingdom: A Cost-Utility and Budget Impact AnalysisPharmacoEconomics - OpenTara Danying Li, C. Rinciog, Araadhna Sinha et al.University of Sheffield; Keele University; Nottingham University Hospitals NHS Trust
2026-10-26Economic Evaluation of an E-Dengue Early Warning System for Proactive Dengue Prevention in the Mekong Delta Region, Vietnam: A ProtocolPharmacoEconomics - OpenTrinh Manh Hung, Kim-Huong Nguyen, Hugo C. Turner et al.The University of Queensland; Trinity College Dublin; Imperial College London; …
2026-10-26Quality-Adjusted and Disability-Adjusted Life Years (QALYs and DALYs): An Overview and Guide to CalculationsPharmacoEconomics - OpenHugo Turner, Brandon Wen Bing Chua, Panupong Chaowanasawat et al.Imperial College London; Health Intervention and Technology Assessment Program; The University of Queensland; …
2026-10-21Hospital Burden and Care Pathways of ANCA-Associated Vasculitis in Italy: A Focus on Clinical, Economic, and Geographic DimensionsPharmacoEconomics - OpenHelen Banks, Giovanni Fattore, Claudio Jommi et al.Bocconi University; Università degli Studi del Piemonte Orientale “Amedeo Avogadro”; Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia; …
2026-10-13Health State Valuation in Nigeria: An Insight into Discrete Choice Experiment-Based Preferences for Children and Adolescents from the Lenses of Adult RespondentsPharmacoEconomics - OpenAbdulmuminu Isah, Iheomimichineke Ojiakor, Chinelo Obi et al.University of Nigeria; Kenya Medical Research Institute; KEMRI-Wellcome Trust Research Programme; …
2026-10-12Conceptualising Health Economic Models Using a Graph Retrieval-Augmented, Agentic AI Framework with Human-in-the-Loop Validation: Proof-of-Concept StudyPharmacoEconomics - OpenTushar Srivastava, Hanan Irfan, Shilpi Swami
2026-10-10The Economic and Humanistic Burden of Phenylketonuria Among Patients and Their Caregivers: A Systematic Literature ReviewPharmacoEconomics - OpenJudit Józwiak‐Hagymásy, Tamás Zelei, Shailja Vaghela et al.Syreon Research Institute (Hungary); Moderna Therapeutics (United States); Semmelweis University
2026-10-05Budget Impact Model of a Novel cfRNA Test-and-Treat Strategy for Preeclampsia in Advanced Maternal Age Pregnancies Compared with Current GuidelinesPharmacoEconomics - OpenApril Zambelli-Weiner, Brian Harris Nathanson, Susan HahnJohns Hopkins University; Surrozen, Inc. (United States)
2026-10-02Generalized Pustular Psoriasis: A Cost-of-Illness and Health-Related Quality of Life Study in ItalyPharmacoEconomics - OpenLudovica Borsoi, Patrizio Armeni, Annalisa Maddalena Scopinaro et al.Bocconi University; Azienda Ospedaliera Universitaria Integrata Verona
2026-10-02Cost-Effectiveness Analysis of Ribociclib plus an Aromatase Inhibitor (AI) Versus AI Alone in the Adjuvant Treatment of Stage II and III Pre- and Postmenopausal Women with HR+/HER2− Early Breast Cancer (EBC): A Canadian Payer PerspectivePharmacoEconomics - OpenDina Soliman, Christine Brezden‐Masley, Sandeep R. Sehdev et al.Novartis (Canada); Mount Sinai Hospital; Ottawa Hospital
2026-10-02Healthcare Utilization and Direct Medical Costs of Hepatocellular Carcinoma Treatment — A German Claims Data Study of 2778 PatientsPharmacoEconomics - OpenSelina Becht, Sami Orabi, Simone Schrodi et al.LMU Klinikum; Ludwig-Maximilians-Universität München; Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie; …
Cite this page

Scholar4AI. (2026). PharmacoEconomics - Open. Journal Research Rankings. Retrieved October 30, 2026, from https://scholar4ai.com/journals/pharmacoeconomics-open

@misc{scholar4ai-journals-pharmacoeconomics-open,
  author = {{Scholar4AI}},
  title = {PharmacoEconomics - Open},
  year = {2026},
  howpublished = {\url{https://scholar4ai.com/journals/pharmacoeconomics-open}},
  urldate = {2026-10-30},
  note = {Journal Research Rankings; data from OpenAlex (CC0); licensed CC BY-NC 4.0}
}

Free to reuse for non-commercial purposes with attribution (CC BY-NC 4.0).